WithdrawnNot Applicable

Non-interventional Study in Pediatric Patients Treated With NOVOCART Inject in the Knee

Stopped: A waiver was granted for paediatric patients. Therefore, the study is not necessary.

Germany0Started 2025-05

Plain-language summary

The study is a prospective, multicenter, single-arm non-interventional study to evaluate the efficacy, safety and health economics of NOVOCART® Inject in the treatment of cartilage defects of the knee in pediatric patients with radiologically proven closed epiphyseal growth plates.

Who can participate

Age range17 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Pediatric patients (\< 18 years of age at implantation) * Closure of the epiphysis adjacent to the biopsy harvest site or the defect to be treated confirmed by an adequate imaging modality * Localized full-thickness cartilage defect (ICRS grade III or IV) of the knee * Medicinal indication for NOVOCART® Inject treatment Exclusion Criteria: see NOVOCART Inject SmPC

What they're measuring

Responder rate of overall KOOS

Timeframe: 24-months Follow-up

Trial details

NCT IDNCT05391841

SponsorTetec AG

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2029-05

View on ClinicalTrials.gov More Cartilage Disease trials